| INDIVIOR PLC DL 0,50 |
| Großbritannien |
| Gesundheit |
| GB00BN4HT335 / A3DWFC |
| 2IVB (Frankfurt) / INDV (NASDAQ) |
| FRA:2IVB, ETR:2IVB, 2IVB:GR, NASDAQ:INDV |
| - |
| https://www.indivior.com/.. |
|
Indivior PLC is a specialty pharmaceutical company renowned for its development, manufacture, and commercialization of medications targeting addiction and serious mental health disorders. The company's primary function is to address the global epidem..
>Volltext.. |
| 3293.5 Mio. EUR |
| 3428.65 Mio. EUR |
| 1074.23 Mio. EUR |
| 327.47 Mio. EUR |
| 181.06 Mio. EUR |
| 1.45 EUR |
| 304.08 Mio. EUR |
| 168.93 Mio. EUR |
| -23.6 Mio. EUR |
| 0.21 |
| 4.38% |
| - |
| - |
| - |
| - |
| 16.06.16 - 2.0377499€ 17.09.15 - 0.73407995€ |
| INDIVIOR |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|